間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf
如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf
產(chǎn)品型號: MSCM-acf；
產(chǎn)品展商: ScienCell
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 上海 安徽 合肥 ScienCell細(xì)胞庫?
間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf
的詳細(xì)介紹
Mesenchymal Stem Cell medium-animal component free (MSCM-acf) is designed for optimal growth and expansion of normal mesenchymal stem cells (MSCs) in vitro. MSCs can be expanded for several passages while maintaining their multipotential phenotype. It is a sterile, liquid medium which contains non-animal source essential and non-essential amino acids, vitamins, organic and inorganic compounds, hormones, growth factors, trace minerals. The medium is HEPES and bicarbonate buffered and has a pH of 7.4 when equilibrated in an incubator with an atmosphere of 5% CO2/95% air. The medium is formulated (quantitatively and qualitatively) to provide a defined and optimally balanced nutritional environment at serumfree condition that selectively promotes growth of normal human mesenchymal stem cells in vitro.
|
貨號
|
7521
|
|
產(chǎn)地
|
美國
|
|
縮寫
|
MSCM-acf
|
|
規(guī)格
|
500ml
|
|
用途
|
科研
|
|
儲存
|
4度，-20度
|
|
運(yùn)輸
|
膠冰
|
|
關(guān)鍵字
|
間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf 間充質(zhì)干細(xì)胞培養(yǎng)基 MSCM-acf
|
公司簡介
|
合肥星肽生物科技有限公司作為專業(yè)的ScienCell中國代理商，專業(yè)經(jīng)營實(shí)驗室科研用原代細(xì)胞、原代細(xì)胞專用培養(yǎng)基、原代細(xì)胞無血清培養(yǎng)基、干細(xì)胞、干細(xì)胞培養(yǎng)基、干細(xì)胞無血清培養(yǎng)基的研究和開發(fā)。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務(wù)，對購買項目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項目準(zhǔn)確到位，都有相關(guān)專業(yè)人士進(jìn)行維護(hù),確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務(wù)！
|
|
聯(lián)系方式
|
何經(jīng)理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://www.28888123.cn QQ:514713116
|
No Publication available at this time
There are no product questions yet.
